P
PMVP
Pmv Pharmaceuticals, Inc.
1.240
-0.090-6.77%After Hours: 1.240 0.000 0.00%19:34 07/24 EDT
OPEN/PREV CLOSE1.340/1.330
TODAY RANGE1.225-1.350
VOL132.02K
MARKET CAP66.13M
52 WEEK RANGE1.020-1.880
AVG VOL (3M)328.53K
% TURNOVER0.25%
TURNOVER--
P/E (TTM)-0.8365
% RANGE9.02%
EPS(TTM)-1.4824
P/E(FORWARD)-0.8702
P/B0.7518
BVPS1.649
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP63.92M
SHARES OUTSTANDING53.33M
NEXT EARNINGS08/05-08/10
FREE FLOAT51.55M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·07/08 15:15
PMV Pharmaceuticals Price Target Announced at $3.00/Share by Ladenburg Thalmann
Dow Jones·07/08 15:15
PMV Pharmaceuticals Coverage Assumed by Ladenburg Thalmann at Buy
TipRanks·07/08 11:46
PMV Pharmaceuticals assumed with a Buy at Ladenburg
NASDAQ·06/24 16:00
PMV Pharmaceuticals (PMVP) Upgraded to Buy: Here's Why
TipRanks·06/05 12:29
PMV Pharmaceuticals Shareholders Back Directors and Governance Matters
Simply Wall St·05/19 11:29
PMV Pharmaceuticals (NASDAQ:PMVP) Will Have To Spend Its Cash Wisely
Benzinga·05/13 21:06
12 Health Care Stocks Moving In Wednesday's After-Market Session
Dow Jones·05/13 17:24
PMV Pharmaceuticals Is Maintained at Outperform by Oppenheimer
Dow Jones·05/13 17:24
PMV Pharmaceuticals Price Target Cut to $5.00/Share From $6.00 by Oppenheimer
Reuters·05/13 12:40
PMV PHARMACEUTICALS <PMVP.O>: OPPENHEIMER CUTS TARGET PRICE TO $5 FROM $6
Reuters·05/13 07:31
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
TipRanks·05/12 16:19
PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)